Announcement on Implementation of Dividend Distribution for Q1-Q3 2025
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
Announcement on Implementation of Dividend Distribution for Q1-Q3 2025
Filed with SSE ·
6ix hasn’t read this filing yet.
Henan Taloph Pharmaceutical Stock Co. Ltd. on 6ix
Earlier from Henan Taloph Pharmaceutical Stock
- Announcement on Using Idle Self-owned Funds for Entrusted Wealth Management
- Plan for Issuing A-shares to Specific Objects in 2025
- Announcement on Continued Stock Suspension Due to Controlling Shareholder's Planning of Major Matters
- Announcement on Stock Suspension Due to Controlling Shareholder's Planning of Major Matters
- Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business License for Wholly-owned Subsidiary
Later from Henan Taloph Pharmaceutical Stock
- Announcement on Change of "Drug Manufacturing License"
- Announcement on Progress in Providing Guarantee for Financing of Subordinated Holding Subsidiary
- Announcement on Adjusting Guarantee Amount among Subsidiaries and Providing Guarantee for Subsidiaries
- Announcement on Progress in Receiving the "Decision on No Further Review of the Anti-Monopoly Examination for Concentration of Undertakings" and Proposed Change of Controlling Shareholder and Actual Controller
- Announcement on Results of Issuing Phase I Ultra-Short-Term Financing Bonds of 2026
Follow Henan Taloph Pharmaceutical Stock into a list and get an email when it puts out news.
Follow Henan Taloph Pharmaceutical Stock